Levated Psa News Today

New research suggests that review of current prostate cancer screening guidelines may be needed, as MRI frequently fails to detect cancer-indicative lesions, even in men with elevated PSA levels.

Clinicians anticipate the newest way to treat a common cause of urinary symptoms in older men.

The newly approved device from Urotronic relieves enlarged prostate symptoms without requiring burns or implants.

A large study from Germany found that digital rectal examination had low detection rates compared with prostate-specific antigen testing in men in their mid-to-late 40s.

Compared with systematic biopsy, MRI-directed targeted biopsy found fewer harmless tumors but did delay detection of some intermediate-risk tumors.

A low score completely rules out grade 2 or higher prostate cancer on repeat biopsy. The study was published as a preprint and has not yet been peer reviewed.

A validated genetic score can adjust PSA values to reduce overdiagnosis of prostate cancer and help distinguish clinically significant disease from indolent cancer.

Contrary to national guidelines, more than a quarter of US cancer centers do not recommend shared decision-making before initiating PSA screening.

Imaging techniques might be accurate enough to replace biopsies for prostate cancer in select patients.